Positive interim safety results from the first two dose escalation cohorts, referred to as Cohorts 1 and 2, were reported in 4Q 2024. Today’s update is focused on safety and molecular findings from ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

SCIENTISTS claim they’ve ‘rejuvenated’ human eggs for the first time – reversing their age in a breakthrough that has the ...

Experts discuss the critical unmet needs in HER2-mutant non-small cell lung cancer, highlighting disparities in testing and ...

Uncertain about how you can stay healthy on a tight budget, especially when bombarded with misinformation from social media ...

First of all, we will live longer. A study on survival after Alzheimer’s diagnosis found that people diagnosed at age 65 had ...

Agyemang, has stressed the need for comprehensive support for families affected by sickle cell disease in Ghana.

Our year in review highlights the achievements, resilience and spirit of our community. From sports championships and ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Sydney mum Amy Busdon shares her breast cancer story to remind other young women to listen to their bodies and act early.